Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA).
This study is enrolling at both Buffalo & Rochester locations.
COVID Vaccine
Age Range:
50 to 64
Gender:
Male and Female
Location:
Buffalo, New York
About the Study
- Single study vaccination on Day 0, then health check-ins through ~6 months to monitor safety and effectiveness.
- Visit schedule: a screening visit and a vaccination visit, with scheduled follow-ups through 6 months (your exact office and check-in schedule will be confirmed at screening).
Qualifications
- Age 50 to <65 at the time of vaccination.
- Generally healthy (not considered at high risk for severe COVID-19).
* Other qualifications may apply.
FEATURED STUDIES
Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. […]
Rochester Clinical Research (RCR) is enrolling volunteers for a research study testing an investigational pneumococcal vaccine. This study is looking […]
Rochester Clinical Research in Buffalo is conducting a research study focused on Lyme disease prevention.
Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate […]
Rochester Clinical Research is taking part in a new study evaluating an updated COVID-19 vaccine for generally healthy patients ages […]
Rochester Clinical Research is currently enrolling adults 18 years and older for a research study to learn if a series […]